<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03986775</url>
  </required_header>
  <id_info>
    <org_study_id>AFCRO-066</org_study_id>
    <nct_id>NCT03986775</nct_id>
  </id_info>
  <brief_title>Efficacy of Palatinose™ Versus Sucrose on Flow Mediated Dilation in Healthy Subjects With Mild Hypertension</brief_title>
  <official_title>AFCRO-066: A Double-blinded, Randomized, Controlled, Acute, Cross-over Study to Determine the Efficacy of Palatinose™ Versus Sucrose on Flow Mediated Dilation in Healthy Subjects With Mild Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beneo-Institute</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beneo-Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the efficacy of Palatinose versus sucrose on Flow Mediated Dilation (FMD) in
      healthy subjects with mild hypertension.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2016</start_date>
  <completion_date type="Actual">August 9, 2017</completion_date>
  <primary_completion_date type="Actual">March 3, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brachial ultrasound FMD scan</measure>
    <time_frame>Baseline, 60 minutes, 120 minutes, 180 minutes</time_frame>
    <description>Changes in postprandial flow-mediated Dilation (endothelial function)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postprandial glycemic response</measure>
    <time_frame>Baseline, 60 minutes, 120 minutes, 180 minutes</time_frame>
    <description>Postprandial glycemic response (Plasma samples)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial insulin response</measure>
    <time_frame>Baseline, 60 minutes, 120 minutes, 180 minutes</time_frame>
    <description>Postprandial Insulin response (Plasma samples)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Overweight and Obesity</condition>
  <arm_group>
    <arm_group_label>citrus drink with isomaltulose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>citrus drink with sucrose</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>isomaltulose</intervention_name>
    <description>replacement of sucrose with low-glycemic isomaltulose</description>
    <arm_group_label>citrus drink with isomaltulose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>sucrose</intervention_name>
    <description>conventional beverage with sucrose</description>
    <arm_group_label>citrus drink with sucrose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Subject is healthy at the time of pre-examination

          -  Subject has a BMI of 25 - 35 kg/m²

          -  Subject is aged 25 - 50 years at the time of pre-examination

          -  Signed written informed consent

          -  Inactive (IPAQ score &lt;1)

          -  Waist to Hip ratio ≥0.90 cm for males, ≥0.85 cm for females

          -  High-normo/Mild hypertensive (SBP: 130-159 mmHg / DBP: 80-99 mmHg)

        Exclusion criteria:

          -  Use of medication interfering with RAAS, such as ACE-inhibitors,

          -  Advanced cardio-vascular disease (CVD),

          -  Severe kidney disorders (CKD),

          -  Diabetes mellitus, both type 1 and II diabetes,

          -  Pregnant, lactating or wish to become pregnant,

          -  Hypersensitivity to any of the components of the test product,

          -  Restricted diet (vegetarian)

          -  Thyroid disease

          -  Heavy Smokers (light smokers allowed)

          -  Lack of suitability for participation in the trial, for any medical reason, as judged
             by the PI.

          -  Excessive alcohol consumption (&gt;21 units/week for males &amp; &gt;14 units/week for females)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 11, 2019</study_first_submitted>
  <study_first_submitted_qc>June 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2019</study_first_posted>
  <last_update_submitted>June 14, 2019</last_update_submitted>
  <last_update_submitted_qc>June 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glycemic Index</keyword>
  <keyword>Overweight</keyword>
  <keyword>Endothelial function</keyword>
  <keyword>carbohydrate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

